QQ客服 官方微博 反馈留言

浏览/检索结果: 共26条，第1-10条 帮助 限定条件 发表日期：2017    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer 期刊论文 CURRENT MEDICINAL CHEMISTRY, 2017, 卷号: 24, 期号: 6, 页码: 590-613 作者:  Liu, Jingru;  Ma, Shutao 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 ALK  NSCLC  inhibitors  point mutations  biological activity  SAR   Long-term outcomes of stage I NSCLC (<= 3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 11, 页码: 4561-+ 作者:  Qu, Xiao;  Wang, Kai;  Zhang, Tiehong;  Shen, Hongchang;  Dong, Wei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 Segmentectomy  lobectomy  non-small cell lung cancer (NSCLC)  prognosis  lymph nodes (LN)   Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 34, 页码: 56714-56725 作者:  Wei, Zhigang;  Ye, Xin;  Yang, Xia;  Zheng, Aimin;  Huang, Guanghui 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 epidermal growth factor receptor  tyrosine kinase inhibitors  non-small  cell lung cancer  microwave ablation  progression free survival   Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST) A case report 期刊论文 MEDICINE, 2017, 卷号: 96, 期号: 10 作者:  Ding, Xingchen;  Wang, Linlin;  Liu, Xijun;  Sun, Xindong;  Yu, Jinming 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 early-stage NSCLC  EGFR-TKI  genetic examination  metachronous second  primary tumor  therapy   Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 8, 页码: 13304-13311 作者:  Zhu, Qianqian;  Sun, Yanan;  Cui, Yingying;  Ye, Ke;  Yang, Chengliang 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 non-small cell lung cancer  brain metastases  epidermal growth factor  receptor  tyrosine kinase inhibitors  radiotherapy   Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway 期刊论文 INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 卷号: 13, 期号: 12, 页码: 1560-1569 作者:  Yu, Chenxiao;  Jiao, Yang;  Xue, Jiao;  Zhang, Qi;  Yang, Hongying 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 non-small cell lung cancer (NSCLC)  epigallocatechin-3-gallate (EGCG)  1-(diaminomethylidene)-3  3-dimethylguanidine (metformin)  NF-E2-related  factor 2 (Nrf2)  heme oxygenase-1 (HO-1)   Percutaneous microwave ablation (MWA) increased the serum levels of VEGF and MMP-9 in Stage I non-small cell lung cancer (NSCLC) 期刊论文 INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2017, 卷号: 33, 期号: 4, 页码: 435-439 作者:  Ni, Yang;  Ye, Xin;  Wan, Chao;  Ni, Qing;  Yang, Xia 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 Microwave ablation (MWA)  VEGF  MMP-9  non-small cell lung cancer  (NSCLC)   Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report 期刊论文 Medicine, 2017, 期号: 10, 页码: e6221-e6221 作者:  Xingchen.Ding;  Linlin.Wang;  Xijun.Liu;  Xindong.Sun;  Ji 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/11 Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 15, 页码: 24564-24578 作者:  Li, Chunyu;  Yin, Yunhong;  Liu, Xiao;  Xi, Xuejiao;  Xue, Weixiao 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/11 NSCLC  microRNA  robust rank aggregation  integrative analysis  biomarker   Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 43, 页码: 74910-74916 作者:  Zhang Nasha;  Kong Li;  Shi Fang;  Jing Wang;  Wang Haiyong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 CEA kinetic change  progression  metastatic NSCLC  maintenance therapy  bevacizumab